Home > Insider Trading > Filing (0001192482-18-000107)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651561	Tabula Rasa Healthcare Inc.	TRHC	()	4/A

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
902959	R Glen Bressner	205 Webster Street Bethlehem PA 18015	Yes	No	No	Yes
1125761	J Michael Gausling	205 Webster Street Bethlehem PA 18015	No	No	No	Yes
1384605	Originate Growth Fund 1Q Lp	205 Webster Street Bethlehem PA 18015	No	No	No	Yes
1685914	Originate Growth Gp, Llc	205 Webster Street Bethlehem PA 18015	No	No	No	Yes
1685942	R Eric Arnson	205 Webster Street Bethlehem PA 18015	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-12-08	523,805	$25.85	1,390,723	No	4	S	Direct
Common Stock	Disposition	2017-12-11	160,375	$25.85	1,229,898	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
This report is filed jointly by Originate Growth Fund #1Q, L.P. ("Originate #1Q"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.